Obesity is not associated with increased myelosuppression in patients receiving chemotherapy for breast cancer
- 1 February 2007
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 43 (3) , 544-548
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Undertreatment of Obese Women Receiving Breast Cancer ChemotherapyArchives of internal medicine (1960), 2005
- Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experienceAnnals of Oncology, 2004
- Are medical oncologists biased in their treatment of the large woman with breast cancer?Breast Cancer Research and Treatment, 2001
- Pooled Analysis of Prospective Cohort Studies on Height, Weight, and Breast Cancer RiskAmerican Journal of Epidemiology, 2000
- Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541.Journal of Clinical Oncology, 1996
- Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.Journal of Clinical Oncology, 1996
- Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-upNew England Journal of Medicine, 1995
- Obesity as an Adverse Prognostic Factor for Patients Receiving Adjuvant Chemotherapy for Breast CancerAnnals of Internal Medicine, 1994
- The calculation of actual or received dose intensity: a comparison of published methods.Journal of Clinical Oncology, 1991
- CLINICAL CALORIMETRYArchives of internal medicine (1908), 1916